BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8325377)

  • 1. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency.
    Horiuchi M; Yoshida H; Kobayashi K; Kuriwaki K; Yoshimine K; Tomomura M; Koizumi T; Nikaido H; Hayakawa J; Kuwajima M
    FEBS Lett; 1993 Jul; 326(1-3):267-71. PubMed ID: 8325377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency.
    Kuwajima M; Lu K; Sei M; Ono A; Hayashi M; Ishiguro K; Ozaki K; Hotta K; Okita K; Murakami T; Miyagawa J; Narama I; Nikaido H; Hayakawa J; Nakajima H; Namba M; Hanafusa T; Matsuzawa Y; Shima K
    J Mol Cell Cardiol; 1998 Apr; 30(4):773-81. PubMed ID: 9602426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Asai T; Okumura K; Takahashi R; Matsui H; Numaguchi Y; Murakami H; Murakami R; Murohara T
    Cardiovasc Res; 2006 Jun; 70(3):566-77. PubMed ID: 16546150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency.
    Yoshimine K; Horiuchi M; Suzuki S; Kobayashi K; Abdul JM; Masuda M; Tomomura M; Ogawa Y; Itoh H; Nakao K; Osame M; Saheki T
    J Mol Cell Cardiol; 1997 Feb; 29(2):571-8. PubMed ID: 9140816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Takahashi R; Okumura K; Asai T; Hirai T; Murakami H; Murakami R; Numaguchi Y; Matsui H; Ito M; Murohara T
    Cardiovasc Res; 2005 Nov; 68(2):213-23. PubMed ID: 15963478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency.
    Jalil A; Horiuchi M; Nomoto M; Kobayashi K; Saheki T
    Life Sci; 1999; 64(13):1137-44. PubMed ID: 10210276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of cardiac hypertrophy in carnitine-deficient juvenile visceral steatosis (JVS) mice achieved by lowering dietary lipid.
    Jalil MA; Horiuchi M; Wakamatsu M; Li MX; Begum L; Suzuki K; Kobayashi K; Oka T; Saheki T
    J Biochem; 2006 Feb; 139(2):263-70. PubMed ID: 16452314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation.
    Takahashi R; Asai T; Murakami H; Murakami R; Tsuzuki M; Numaguchi Y; Matsui H; Murohara T; Okumura K
    Hypertension; 2007 Sep; 50(3):497-502. PubMed ID: 17664396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine transport defect in fibroblasts of juvenile visceral steatosis (JVS) mouse.
    Kuwajima M; Lu K; Harashima H; Ono A; Sato I; Mizuno A; Murakami T; Nakajima H; Miyagawa J; Namba M; Hanafusa T; Hayakawa J; Matsuzawa Y; Shima K
    Biochem Biophys Res Commun; 1996 Jun; 223(2):283-7. PubMed ID: 8670273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant changes in the hypertrophied heart due to energy metabolic disorder.
    Kamiya H; Okumura K; Ito M; Matsui H; Saburi Y; Hayashi K; Hayakawa T
    Basic Res Cardiol; 2001 Sep; 96(5):431-8. PubMed ID: 11605989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder.
    Saburi Y; Okumura K; Matsui H; Hayashi K; Kamiya H; Takahashi R; Matsubara K; Ito M
    Cardiovasc Res; 2003 Jan; 57(1):92-100. PubMed ID: 12504818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carnitine deprivation on carnitine homeostasis and energy metabolism in mice with systemic carnitine deficiency.
    Knapp AC; Todesco L; Torok M; Beier K; Krähenbühl S
    Ann Nutr Metab; 2008; 52(2):136-44. PubMed ID: 18417958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The signaling pathway of cardiotrophin-1 is not activated in hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice.
    Yoshida G; Horiuchi M; Kobayashi K; Jalil MD; Iijima M; Hagihara S; Nagao N; Saheki T
    In Vivo; 2000; 14(3):401-5. PubMed ID: 10904873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency.
    Miyagawa J; Kuwajima M; Hanafusa T; Ozaki K; Fujimura H; Ono A; Uenaka R; Narama I; Oue T; Yamamoto K
    Virchows Arch; 1995; 426(3):271-9. PubMed ID: 7773507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of alpha-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol.
    Takahashi R; Okumura K; Matsui H; Saburi Y; Kamiya H; Matsubara K; Asai T; Ito M; Murohara T
    Cardiovasc Res; 2003 Jun; 58(3):565-74. PubMed ID: 12798429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood.
    Tomomura M; Tomomura A; Musa DA; Horiuchi M; Takiguchi M; Mori M; Saheki T
    J Biochem; 1997 Jan; 121(1):172-7. PubMed ID: 9058209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder.
    Kamiya H; Okumura K; Ito M; Saburi Y; Tomida T; Hayashi K; Matsui H; Hayakawa T
    Can J Cardiol; 2001 Dec; 17(12):1292-8. PubMed ID: 11773940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate dehydrogenase kinase 4 mRNA is increased in the hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice.
    Horiuchi M; Kobayashi K; Masuda M; Terazono H; Saheki T
    Biofactors; 1999; 10(2-3):301-9. PubMed ID: 10609898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency.
    Nakajima T; Horiuchi M; Yamanaka H; Kizaki Z; Inoue F; Kodo N; Kinugasa A; Saheki T; Sawada T
    Pediatr Res; 1997 Jul; 42(1):108-13. PubMed ID: 9212045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system.
    Horiuchi M; Kobayashi K; Yamaguchi S; Shimizu N; Koizumi T; Nikaido H; Hayakawa J; Kuwajima M; Saheki T
    Biochim Biophys Acta; 1994 Apr; 1226(1):25-30. PubMed ID: 8155735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.